---
title: Aldeyra Therapeutics vs Syneos Health
slug_a: aldeyra
slug_b: syneoshealth
site: cro
review_signal_gate: closed
canonical_path: /compare/aldeyra/syneoshealth
generated_by: BioBM Editorial AI
---

# Aldeyra Therapeutics vs Syneos Health

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Aldeyra Therapeutics (aldeyra) is listed for cro. Biopharmaceutical company developing immunomodulatory therapies for immune-mediated ocular and systemic diseases, with late-stage clinical candidates targeting dry eye disease, allergic conjunctivitis, and retinal conditions.

Services: 5. Modalities: 1. Indications: 3. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Syneos Health (syneoshealth) is listed for cro. Global CRO with 26,000+ employees offering integrated clinical development, regulatory affairs, and commercialization services. Helped develop or commercialize 96% of FDA-approved oncology drugs and 93% of EMA-authorized oncology products in the last five years.

Services: 19. Modalities: 7. Indications: 13. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (19).

Review summary: Review summary withheld until site-level review gate opens.